Forschungsbeiträge von Frau Prof. Korn
Publikationen und Co-Autorenschaften
*Auszug aus dem PubMed-Register
(https://pubmed.ncbi.nlm.nih.gov):
Real-World Data on Tezepelumab in Patients With Severe Asthma in Germany.
J Allergy Clin Immunol Pract. 2024 Sep
Authors: Biener L, Mümmler C, Hinze CA, Suhling H, Korn S, Fisser C, Biener A, Pizarro C, Lenoir A, Hackl C, Skowasch D, Milger K.
Validation of the German version of the Asthma Impairment and Risk Questionnaire (AIRQ).
Pneumologie. 2024 Jul 11. doi
Authors: Kanniess F, Defosse K, Lommatzsch M, Schultz T, Timmermann H, Schmidt O, Heindl S, Baumann HJ, Buhl R, Taube C, Höing F, Korn S.
German asthma net: Nasal polyposis in patients in the severe asthma registry.
Allergy. 2024 Jun 12. doi
Authors: Bal C, Stoshikj S, Milger K, Skowasch D, Gappa M, Koerner-Rettberg C, Jandl M, Schmidt O, Ehmann R, Taube C, Hamelmann E, Buhl R, Korn S, Idzko M.
Tezepelumab in patients with allergic and eosinophilic asthma.
Allergy. 2024 May
Authors: Caminati M, Buhl R, Corren J, Hanania NA, Kim H, Korn S, Lommatzsch M, Martin N, Matucci A, Nasser SM, Pavord ID, Domingo C.
Biomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with Asthma.
Am J Respir Crit Care Med. 2024 Apr 15
Authors: Pavord ID, De Prado Gómez L, Brusselle G, Jackson DJ, Brightling CE, Papi A, Maspero JF, Rabe KF, Korn S, Zhang M, Soler X, Jacob-Nara JA, Hardin M; QUEST Lung Function Decline Study Group.
As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort.
ERJ Open Res. 2024 Apr 8
Authors: Hinze CA, Ehmann R, Jandl M, Milger K, Schmidt O, Schulz C, Skowasch D, Welte T, Buhl R, Hamelmann E, Idzko M, Taube C, Korn S, Suhling H.
Long-Term Dupilumab Efficacy on Severe Exacerbations and Lung Function in Patients with Type 2 Asthma.
Ann Am Thorac Soc. 2024 Apr
Authors: Papi A, Castro M, Busse WW, Langton D, Korn S, Xia C, Soler X, Pandit-Abid N, Radwan A, Jacob-Nara JA, Rowe PJ, Deniz Y.
Pioneering a paradigm shift in asthma management: remission as a treatment goal.
Lancet Respir Med. 2024 Feb
Authors: Lommatzsch M, Buhl R, Canonica GW, Ribas CD, Nagase H, Brusselle GG, Jackson DJ, Pavord ID, Korn S, Milger K, Taube C, Virchow JC.
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study.
Lancet. 2024 Jan 20
Authors: Jackson DJ, Heaney LG, Humbert M, Kent BD, Shavit A, Hiljemark L, Olinger L, Cohen D, Menzies-Gow A, Korn S; SHAMAL Investigators.
Real-World Characteristics of Patients with Severe Asthma prior to Starting Dupilumab: The ProVENT Study.
Respiration. 2024
Authors: Korn S, Schmidt O, Timmermann H, Watz H, Gappa M, Radwan A, De Prado Gómez L, Atenhan A, Barbus S, Thakur M, Lommatzsch M.
Bronchodilator Reversibility in the GAN Severe Asthma Cohort.
J Investig Allergol Clin Immunol. 2023 Dec 14
Authors: Milger K, Skowasch D, Hamelmann E, Mümmler C, Idzko M, Gappa M, Jandl M, Körner-Rettberg C, Ehmann R, Schmidt O, Taube C, Holtdirk A, Timmermann H, Buhl R, Korn S.
Initiation, response assessment, and switch of antibody therapies in patients with severe asthma - A survey among German specialists.
World Allergy Organ J. 2023 Nov 15
Authors: Suhling H, Skowasch D, Bergmann KC, Mümmler C, Buhl R, Ehmann R, Hamelmann E, Idzko M, Margret Jandl, Schulz C, Schmidt O, Taube C, Korn S, Milger K; GAN registry group.
Characterization of Austrian severe asthma patients.
Respir Med. 2023 Nov-Dec
Authors: Renner A, Stoshikj S, Pohl W, Bal C, Reisinger M, Löffler-Ragg J, Zacharasiewicz A, Buhl R, Hamelmann E, Taube C, Korn S, Idzko M.
Characterization of Obesity in Severe Asthma in the German Asthma Net.
J Allergy Clin Immunol Pract. 2023 Nov
Authors: Bal C, Pohl W, Milger K, Skowasch D, Schulz C, Gappa M, Koerner-Rettberg C, Jandl M, Schmidt O, Zehetmayer S, Taube C, Hamelmann E, Buhl R, Korn S, Idzko M; German Asthma Net (GAN) study group.
Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort.
J Allergy Clin Immunol Pract. 2023 Sep
Authors: Milger K, Suhling H, Skowasch D, Holtdirk A, Kneidinger N, Behr J, Timmermann H, Schulz C, Schmidt O, Ehmann R, Hamelmann E, Idzko M, Taube C, Lommatzsch M, Buhl R, Korn S.
Criteria for evaluation of response to biologics in severe asthma - the Biologics Asthma Response Score (BARS).
Pneumologie. 2023 Aug 25. doi
Authors: Milger K, Korn S, Feder C, Fuge J, Mühle A, Schütte W, Skowasch D, Timmermann H, Suhling H.
[Diagnosis and treatment of asthma: a guideline for respiratory specialists 2023 - published by the German Respiratory Society (DGP) e. V.].
Pneumologie. 2023 Aug
Authors: Lommatzsch M, Criée CP, de Jong CCM, Gappa M, Geßner C, Gerstlauer M, Hämäläinen N, Haidl P, Hamelmann E, Horak F, Idzko M, Ignatov A, Koczulla AR, Korn S, Köhler M, Lex C, Meister J, Milger-Kneidinger K, Nowak D, Pfaar O, Pohl W, Preisser AM, Rabe KF, Riedler J, Schmidt O, Schreiber J, Schuster A, Schuhmann M, Spindler T, Taube C, Christian Virchow J, Vogelberg C, Vogelmeier CF, Wantke F, Windisch W, Worth H, Zacharasiewicz A, Buhl R; Weitere beteiligte Wissenschaftliche Fachgesellschaften und Organisationen: Deutsche Atemwegsliga e. V.; Deutsche Gesellschaft für Arbeitsmedizin und Umweltmedizin e. V.; Deutsche Gesellschaft für Allergologie und klinische Immunologie e. V.; Deutsche Gesellschaft für Gynäkologie und Geburtshilfe e. V.; Deutsche Gesellschaft für Rehabilitationswissenschaften e. V.; Gesellschaft für Pädiatrische Allergologie und Umweltmedizin e. V.; Gesellschaft für Pädiatrische Pneumologie e. V.; Bundesverband der Pneumologen, Schlaf- und Beatmungsmediziner; Österreichische Gesellschaft für Kinder- und Jugendheilkunde; Österreichische Gesellschaft für Pneumologie; Deutsche Patientenliga Atemwegserkrankungen e. V..
[Diagnosis and treatment of asthma: a guideline for respiratory specialists 2023 - published by the German Respiratory Society (DGP) e. V.].
Pneumologie. 2023 Aug
Authors: Lommatzsch M, Criée CP, de Jong CCM, Gappa M, Geßner C, Gerstlauer M, Hämäläinen N, Haidl P, Hamelmann E, Horak F, Idzko M, Ignatov A, Koczulla AR, Korn S, Köhler M, Lex C, Meister J, Milger-Kneidinger K, Nowak D, Pfaar O, Pohl W, Preisser AM, Rabe KF, Riedler J, Schmidt O, Schreiber J, Schuster A, Schuhmann M, Spindler T, Taube C, Christian Virchow J, Vogelberg C, Vogelmeier CF, Wantke F, Windisch W, Worth H, Zacharasiewicz A, Buhl R; Weitere beteiligte Wissenschaftliche Fachgesellschaften und Organisationen:Deutsche Atemwegsliga e. V.Deutsche Gesellschaft für Arbeitsmedizin und Umweltmedizin e. V.Deutsche Gesellschaft für Allergologie und klinische Immunologie e. V.Deutsche Gesellschaft für Gynäkologie und Geburtshilfe e. V.Deutsche Gesellschaft für Rehabilitationswissenschaften e. V.Gesellschaft für Pädiatrische Allergologie und Umweltmedizin e. V.Gesellschaft für Pädiatrische Pneumologie e. V.Bundesverband der Pneumologen, Schlaf- und BeatmungsmedizinerÖsterreichische Gesellschaft für Kinder- und JugendheilkundeÖsterreichische Gesellschaft für PneumologieDeutsche Patientenliga Atemwegserkrankungen e. V..
Efficacy of Biologics in Severe, Uncontrolled Asthma Stratified by Blood Eosinophil Count: A Systematic Review.
Adv Ther. 2023 Jul
Authors: Korn S, Cook B, Simpson LJ, Llanos JP, Ambrose CS.
Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials.
Am J Respir Crit Care Med. 2023 Jul 1
Authors: Corren J, Menzies-Gow A, Chupp G, Israel E, Korn S, Cook B, Ambrose CS, Hellqvist Å, Roseti SL, Molfino NA, Llanos JP, Martin N, Bowen K, Griffiths JM, Parnes JR, Colice G.
Impact of short-term pausing of oral corticosteroids on blood eosinophil count in patients with severe asthma.
Pneumologie. 2023 Jun
Authors: Biener L, Milger K, Suhling H, Korn S, Pizarro C, Skowasch D.
Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study).
J Asthma Allergy. 2023 May 11
Authors: Korn S, Milger K, Skowasch D, Schulz C, Mohrlang C, Wernitz M, Paulsson T, Hennig M, Buhl R.
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Lancet Respir Med. 2023 May
Authors: Menzies-Gow A, Wechsler ME, Brightling CE, Korn S, Corren J, Israel E, Chupp G, Bednarczyk A, Ponnarambil S, Caveney S, Almqvist G, Gołąbek M, Simonsson L, Lawson K, Bowen K, Colice G; DESTINATION study investigators.
[Criteria for evaluation of response to biologics in severe asthma - the Biologics Asthma Response Score (BARS)].
Pneumologie. 2023 Apr
Authors: Milger K, Korn S, Feder C, Fuge J, Mühle A, Schütte W, Skowasch D, Timmermann H, Suhling H.
Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma.
Eur Respir J. 2023 Mar 9
Authors: Gauvreau GM, Hohlfeld JM, FitzGerald JM, Boulet LP, Cockcroft DW, Davis BE, Korn S, Kornmann O, Leigh R, Mayers I, Watz H, Grant SS, Jain M, Cabanski M, Pertel PE, Jones I, Lecot JR, Cao H, O'Byrne PM.
Overall Response to Anti-IL-5/Anti-IL5-Rα Treatment in Severe Asthma Does Not Depend on Initial Bronchodilator Responsiveness.
J Allergy Clin Immunol Pract. 2022 Dec
Authors: Mümmler C, Suhling H, Walter J, Kneidinger N, Buhl R, Kayser MZ, Drick N, Behr J, Welte T, Korn S, Milger K.
Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study.
ERJ Open Res. 2022 Oct 24
Authors: Frix AN, Heaney LG, Dahlén B, Mihaltan F, Sergejeva S, Popović-Grle S, Sedlak V, Lehtimäki L, Bourdin A, Korn S, Zervas E, Csoma Z, Lúðvíksdóttir D, Butler M, Canonica GW, Grisle I, Bieksiene K, Ten Brinke A, Kuna P, Chaves Loureiro C, Nenasheva NM, Lazic Z, Škrgat S, Ramos-Barbon D, Leuppi J, Gemicioglu B, Bossios A, Porsbjerg CM, Bel EH, Djukanovic R, Louis R.
Safety of combining biologics in severe asthma: Asthma-related and unrelated combinations.
Allergy. 2022 Sep
Authors: Lommatzsch M, Suhling H, Korn S, Bergmann KC, Schreiber J, Bahmer T, Rabe KF, Buhl R, Virchow JC, Milger K.
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study.
Lancet Respir Med. 2022 Jul
Authors: Wechsler ME, Menzies-Gow A, Brightling CE, Kuna P, Korn S, Welte T, Griffiths JM, Sałapa K, Hellqvist Å, Almqvist G, Lal H, Kaur P, Skärby T, Colice G; SOURCE study group.
Fraction of exhaled nitric oxide is associated with disease burden in the German Asthma Net severe asthma cohort.
Eur Respir J. 2022 Jun 2
Authors: Bal C, Idzko M, Škrgat S, Koch A, Milger K, Schulz C, Zehetmayer S, Hamelmann E, Buhl R, Korn S; collaborators from the German Asthma Net (GAN).
Corrigendum to "The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control" [Respir. Med. 195 (2022) 106793].
Respir Med. 2022 May
Authors: Korn S, Milger K, Skowasch D, Timmermann H, Taube C, Idzko M, Voß HW, Holtdirk A, Hamelmann E, Buhl R.
Development of methodology for assessing steroid-tapering in clinical trials for biologics in asthma.
Respir Res. 2022 Mar 4
Authors: Korn S, Howarth P, Smith SG, Price RG, Yancey SW, Prazma CM, Bel EH.
The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control.
Respir Med. 2022 Feb 26
Authors: Korn S, Milger K, Skowasch D, Timmermann H, Taube C, Idzko M, Voß HW, Holtdirk A, Hamelmann E, Buhl R.
Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years.
J Allergy Clin Immunol Pract. 2021 Dec
Authors: Korn S, Bourdin A, Chupp G, Cosio BG, Arbetter D, Shah M, Gil EG.
Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months.
J Asthma Allergy. 2021 Jul 12
Authors: Kayser MZ, Drick N, Milger K, Fuge J, Kneidinger N, Korn S, Buhl R, Behr J, Welte T, Suhling H.
[Guideline for the Diagnosis and Treatment of Asthma - Addendum 2020 - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology].
Pneumologie. 2021 Mar
Authors: Buhl R, Bals R, Baur X, Berdel D, Criée CP, Gappa M, Gillissen A, Greulich T, Haidl P, Hamelmann E, Horak F, Kardos P, Kenn K, Klimek L, Korn S, Magnussen H, Nowak D, Pfaar O, Rabe KF, Riedler J, Ritz T, Schultz K, Schuster A, Spindler T, Taube C, Vogelmeier C, von Leupoldt A, Wantke F, Wildhaber J, Worth H, Zacharasiewicz A, Lommatzsch M; Unter Mitwirkung der folgenden Wissenschaftlichen Gesellschaften: Deutsche Gesellschaft für Arbeitsmedizin und Umweltmedizin e. V.; Deutsche Gesellschaft für Rehabilitationswissenschaften e. V.; Deutsche Gesellschaft für Gynäkologie und Geburtshilfe e. V..
Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma.
J Asthma Allergy. 2020 Nov 11
Authors: Drick N, Milger K, Seeliger B, Fuge J, Korn S, Buhl R, Schuhmann M, Herth F, Kendziora B, Behr J, Kneidinger N, Bergmann KC, Taube C, Welte T, Suhling H.
A Non-Interventional Study of Tiotropium/Olodaterol versus Any Triple Combination Therapy for Chronic Obstructive Pulmonary Disease: The EVELUT® Study Protocol.
Int J Chron Obstruct Pulmon Dis. 2020 Oct 22
Authors: Buhl R, Dreher M, Korn S, Taube C, Stock C, Zehendner CM, Kondla A, Vogelmeier CF.
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)D, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)E, Österreichische Gesellschaft für Pneumologie (ÖGP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)H.
Allergol Select. 2020 Sep 7
Authors: Klimek L, Pfaar O, Worm M, Eiwegger T, Hagemann J, Ollert M, Untersmayr E, Hoffmann-Sommergruber K, Vultaggio A, Agache I, Bavbek S, Bossios A, Casper I, Chan S, Chatzipetrou A, Vogelberg C, Firinu D, Kauppi P, Kolios A, Kothari A, Matucci A, Palomares O, Szépfalusi Z, Pohl W, Hötzenecker W, Rosenkranz AR, Bergmann KC, Bieber T, Buhl R, Buters J, Darsow U, Keil T, Kleine-Tebbe J, Lau S, Maurer M, Merk H, Mösges R, Saloga J, Staubach P, Jappe U, Rabe KF, Rabe U, Vogelmeier C, Biedermann T, Jung K, Schlenter W, Ring J, Chaker A, Wehrmann W, Becker S, Freudelsperger L, Mülleneisen N, Nemat K, Czech W, Wrede H, Brehler R, Fuchs T, Tomazic PV, Aberer W, Fink-Wagner AH, Horak F, Wöhrl S, Niederberger-Leppin V, Pali-Schöll I, Pohl W, Roller-Wirnsberger R, Spranger O, Valenta R, Akdis M, Matricardi PM, Spertini F, Khaltaev N, Michel JP, Nicod L, Schmid-Grendelmeier P, Idzko M, Hamelmann E, Jakob T, Werfel T, Wagenmann M, Taube C, Jensen-Jarolim E, Korn S, Hentges F, Schwarze J, O Mahony L, Knol EF, Del Giacco S, Chivato Pérez T, Bousquet J, Bedbrook A, Zuberbier T, Akdis C, Jutel M.
Prospective, Single-Arm, Longitudinal Study of Biomarkers in Real-World Patients with Severe Asthma.
J Allergy Clin Immunol Pract. 2020 Sep
Authors: Buhl R, Korn S, Menzies-Gow A, Aubier M, Chapman KR, Canonica GW, Picado C, Donica M, Kuhlbusch K, Korom S, Hanania NA.
The Treatment of Mild and Moderate Asthma in Adults.
Dtsch Arztebl Int. 2020 Jun 19
Authors: Lommatzsch M, Buhl R, Korn S.
Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab.
Drug Saf. 2020 May
Authors: Jackson DJ, Korn S, Mathur SK, Barker P, Meka VG, Martin UJ, Zangrilli JG.
Reslizumab as add-on therapy in patients with refractory asthma.
BMJ Open Respir Res. 2020 Apr
Authors: Virchow JC, McDonald M, Garin M, Korn S.
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA).
J Asthma Allergy. 2020 Feb 17
Authors: Panettieri RA Jr, Welte T, Shenoy KV, Korn S, Jandl M, Kerwin EM, Feijoo R, Barker P, Olsson RF, Martin UJ; SOLANA Study Investigators.
Age- and sex-dependent differences in patients with severe asthma included in the German Asthma Net cohort.
Respir Med. 2020 Feb
Authors: Milger K, Korn S, Buhl R, Hamelmann E, Herth FJ, Gappa M, Drick N, Fuge J, Suhling H.
Characteristics and treatment regimens across ERS SHARP severe asthma registries.
Eur Respir J. 2020 Jan 9
Authors: van Bragt JJMH, Adcock IM, Bel EHD, Braunstahl GJ, Ten Brinke A, Busby J, Canonica GW, Cao H, Chung KF, Csoma Z, Dahlén B, Davin E, Hansen S, Heffler E, Horvath I, Korn S, Kots M, Kuna P, Kwon N, Louis R, Plaza V, Porsbjerg C, Ramos-Barbon D, Richards LB, Škrgat S, Sont JK, Vijverberg SJH, Weersink EJM, Yasinska V, Wagers SS, Djukanovic R, Maitland-van der Zee AH; SHARP Clinical Research Collaboration; Members of the SHARP Clinical Research Collaboration are.
Measurement of Fractional Exhaled Nitric Oxide: Comparison of Three Different Analysers.
Respiration. 2020
Authors: Korn S, Wilk M, Voigt S, Weber S, Keller T, Buhl R.
Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study.
Clin Ther. 2019 Oct
Authors: Khurana S, Brusselle GG, Bel EH, FitzGerald JM, Masoli M, Korn S, Kato M, Albers FC, Bradford ES, Gilson MJ, Price RG, Humbert M.
Tralokinumab did not demonstrate oral corticosteroid-sparing effects in severe asthma.
Eur Respir J. 2019 Jan 31
Authors: Busse WW, Brusselle GG, Korn S, Kuna P, Magnan A, Cohen D, Bowen K, Piechowiak T, Wang MM, Colice G.
Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps.
J Allergy Clin Immunol Pract. 2019 Feb
Authors: Weinstein SF, Katial RK, Bardin P, Korn S, McDonald M, Garin M, Bateman ED, Hoyte FCL, Germinaro M.
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial.
Lancet Respir Med. 2019 Jan
Authors: Busse WW, Bleecker ER, FitzGerald JM, Ferguson GT, Barker P, Sproule S, Olsson RF, Martin UJ, Goldman M; BORA study investigators.
The Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP) ERS Clinical Research Collaboration: a new dawn in asthma research.
Eur Respir J. 2018 Nov 29
Authors: Djukanovic R, Adcock IM, Anderson G, Bel EH, Canonica GW, Cao H, Chung KF, Davies DE, Genton C, Gibson-Latimer T, Hamerlijnck D, Heuvelin E, Louis R, Korn S, Kots M, Kwon N, Naddaf R, Wagers SS; SHARP Clinical Research Collaboration; Members of the CRC-SHARP.
[Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology].
Pneumologie. 2017 Dec
Authors: Buhl R, Bals R, Baur X, Berdel D, Criée CP, Gappa M, Gillissen A, Greulich T, Haidl P, Hamelmann E, Kardos P, Kenn K, Klimek L, Korn S, Lommatzsch M, Magnussen H, Nicolai T, Nowak D, Pfaar O, Rabe KF, Riedler J, Ritz T, Schultz K, Schuster A, Spindler T, Taube C, Taube K, Vogelmeier C, von Leupoldt A, Wantke F, Weise S, Wildhaber J, Worth H, Zacharasiewicz A.
[Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology].
Pneumologie. 2017 Dec
Authors: Buhl R, Bals R, Baur X, Berdel D, Criée CP, Gappa M, Gillissen A, Greulich T, Haidl P, Hamelmann E, Kardos P, Kenn K, Klimek L, Korn S, Lommatzsch M, Magnussen H, Nicolai T, Nowak D, Pfaar O, Rabe KF, Riedler J, Ritz T, Schultz K, Schuster A, Spindler T, Taube C, Taube K, Vogelmeier C, von Leupold A, Wantke F, Weise S, Wildhaber J, Worth H, Zacharasiewicz A.
[Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology].
Pneumologie. 2017 Dec
Authors: Deutsche Gesellschaft für Arbeitsmedizin und Umweltmedizin e. V.; Deutsche Gesellschaft für Rehabilitationswissenschaften e.V.; und Deutsche Gesellschaft für Gynäkologie und Geburtshilfe e.V.;; Buhl R, Bals R, Baur X, Berdel D, Criée CP, Gappa M, Gillissen A, Greulich T, Haidl P, Hamelmann E, Kardos P, Kenn K, Klimek L, Korn S, Lommatzsch M, Magnussen H, Nicolai T, Nowak D, Pfaar O, Rabe KF, Riedler J, Ritz T, Schultz K, Schuster A, Spindler T, Taube C, Taube K, Vogelmeier C, von Leupoldt A, Wantke F, Weise S, Wildhaber J, Worth H, Zacharasiewicz A.
Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma.
N Engl J Med. 2017 Jun 22
Authors: Nair P, Wenzel S, Rabe KF, Bourdin A, Lugogo NL, Kuna P, Barker P, Sproule S, Ponnarambil S, Goldman M; ZONDA Trial Investigators.
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet. 2016 Oct 29
Authors: FitzGerald JM, Bleecker ER, Nair P, Korn S, Ohta K, Lommatzsch M, Ferguson GT, Busse WW, Barker P, Sproule S, Gilmartin G, Werkström V, Aurivillius M, Goldman M; CALIMA study investigators.
GARP inhibits allergic airway inflammation in a humanized mouse model.
Allergy. 2016 Sep
Authors: Meyer-Martin H, Hahn SA, Beckert H, Belz C, Heinz A, Jonuleit H, Becker C, Taube C, Korn S, Buhl R, Reuter S, Tuettenberg A.
Assessing biomarkers in a real-world severe asthma study (ARIETTA).
Respir Med. 2016 Jun
Authors: Buhl R, Korn S, Menzies-Gow A, Aubier M, Chapman KR, Canonica GW, Picado C, Martin N, Escobar RA, Korom S, Hanania NA.
Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial.
Lancet Respir Med. 2015 Sep
Authors: Brightling CE, Chanez P, Leigh R, O'Byrne PM, Korn S, She D, May RD, Streicher K, Ranade K, Piper E.
Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme.
N Engl J Med. 2015 May 21
Authors: Krug N, Hohlfeld JM, Kirsten AM, Kornmann O, Beeh KM, Kappeler D, Korn S, Ignatenko S, Timmer W, Rogon C, Zeitvogel J, Zhang N, Bille J, Homburg U, Turowska A, Bachert C, Werfel T, Buhl R, Renz J, Garn H, Renz H.
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials.
Lancet Respir Med. 2015 May
Authors: Castro M, Zangrilli J, Wechsler ME, Bateman ED, Brusselle GG, Bardin P, Murphy K, Maspero JF, O'Brien C, Korn S.
Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
N Engl J Med. 2014 Sep 25
Authors: Bel EH, Wenzel SE, Thompson PJ, Prazma CM, Keene ON, Yancey SW, Ortega HG, Pavord ID; SIRIUS Investigators.
Mepolizumab treatment in patients with severe eosinophilic asthma.
N Engl J Med. 2014 Sep 25
Authors: Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, Humbert M, Katz LE, Keene ON, Yancey SW, Chanez P; MENSA Investigators.
Tiotropium Respimat® in asthma: a double-blind, randomised, dose-ranging study in adult patients with moderate asthma.
Respir Res. 2014 Jun 3
Authors: Beeh KM, Moroni-Zentgraf P, Ablinger O, Hollaenderova Z, Unseld A, Engel M, Korn S.
[Disease modification and duration of omalizumab treatment in patients with severe allergic asthma].
Pneumologie. 2014 Mar
Authors: Schreiber J, Kopp MV, Korn S, Taube C, Buhl R.
Against all odds: anti-IgE for intrinsic asthma?
Thorax. 2014 Jan
Authors: Lommatzsch M, Korn S, Buhl R, Virchow JC.
Severe and uncontrolled adult asthma is associated with vitamin D insufficiency and deficiency.
Respir Res. 2013 Feb 22
Authors: Korn S, Hübner M, Jung M, Blettner M, Buhl R.
Monitoring free serum IgE in severe asthma patients treated with omalizumab.
Respir Med. 2012 Nov
Authors: Korn S, Haasler I, Fliedner F, Becher G, Strohner P, Staatz A, Taube C, Buhl R.
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
Lancet. 2012 Aug 18
Authors: Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, Ortega H, Chanez P.
Specific IgE against Staphylococcus aureus enterotoxins: an independent risk factor for asthma.
J Allergy Clin Immunol. 2012 Aug
Authors: Bachert C, van Steen K, Zhang N, Holtappels G, Cattaert T, Maus B, Buhl R, Taube C, Korn S, Kowalski M, Bousquet J, Howarth P.
[The German severe asthma registry].
Pneumologie. 2012 Jun
Authors: Korn S, Hübner M, Hamelmann E, Buhl R.
[Treatment strategies for asthma].
Internist (Berl). 2012 Apr
Authors: Korn S, Taube C, Buhl R.
Efficacy of a fixed combination of ciclesonide and formoterol: the EXCITED-study.
Respir Med. 2012 Jan
Authors: Korn S, Buhl R.
Prospective evaluation of current asthma control using ACQ and ACT compared with GINA criteria.
Ann Allergy Asthma Immunol. 2011 Dec
Authors: Korn S, Both J, Jung M, Hübner M, Taube C, Buhl R.
Measurement of exhaled nitric oxide: comparison of different analysers.
Respirology. 2010 Nov
Authors: Korn S, Telke I, Kornmann O, Buhl R.
Effectiveness of omalizumab in patients 50 years and older with severe persistent allergic asthma.
Ann Allergy Asthma Immunol. 2010 Oct
Authors: Korn S, Schumann C, Kropf C, Stoiber K, Thielen A, Taube C, Buhl R.
[Modern management of asthma].
MMW Fortschr Med. 2009 Nov 19
Authors: Haasler I, Korn S, Buhl R, Taube C.
Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany.
Respir Med. 2009 Nov
Authors: Korn S, Thielen A, Seyfried S, Taube C, Kornmann O, Buhl R.
[Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Med Klin (Munich). 2008 May 15
Authors: Korn S, Vogelmeier C, Buhl R.
An open-label, prospective phase I/II study evaluating the immunogenicity and safety of a ras peptide vaccine plus GM-CSF in patients with non-small cell lung cancer.
Lung Cancer. 2007 Oct
Authors: Meyer RG, Korn S, Micke P, Becker K, Huber C, Wölfel T, Buhl R.
Discrepant nasal and bronchial nitric oxide kinetics during early and late phase allergic reactions.
Respir Med. 2005 Dec
Authors: Korn S, Beier J, Heilmann C, Kornmann O, Buhl R, Michael Beeh K.
[Nasal and bronchial provocation with allergen in patients with mild asthma and allergic rhinitis -- similarities and differences].
Pneumologie. 2005 Oct
Authors: Korn S.
Ligamentum paracolicum dextrum--a new ligament?
J Pediatr Surg. 2005 Apr
Authors: Korn S, Konerding MA, Schier F.
Characterization of the interstitial lung and peripheral blood T cell receptor repertoire in cigarette smokers.
Am J Respir Cell Mol Biol. 2005 Feb
Authors: Korn S, Wiewrodt R, Walz YC, Becker K, Mayer E, Krummenauer F, Buhl R.
Aortopexy in esophageal atresia: long-term experience of a parent support group.
J Pediatr Surg. 2001 Oct
Authors: Schier F, Korn S, Michel E.
Experiences of a parent support group with the long-term consequences of esophageal atresia.
J Pediatr Surg. 2001 Apr
Authors: Schier F, Korn S, Michel E.